Skip to main content
TipRanks
Go Ultimate75% OFF

Stratasys (SCY) Q3 2026 Earnings Report

0 Followers

DE:SCY Q3 2026 EPS Results

Actual EPS
EUR 0.04
Consensus EPS
EUR 0.02
Beat/Miss
Beat by +EUR 0.02
One Year Ago EPS
EUR 0.02

DE:SCY Q3 2026 Revenue Results

Actual Revenue
EUR 129.74M
Expected Revenue
EUR 129.07M
Beat/Miss
Beat by +EUR 663.97K
YoY Revenue Growth
+4.14%

Earnings Announcement Details

Quarter
Q3 2026
Date
11/12/2026
Time
Before Open
Conference Call
Thursday, November 12, 2026
DE:SCY Upcoming Earnings

Stratasys's next earnings date is estimated for March 11, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

DE:SCY Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Nov 12, 2026|% Change Since:-14.87%|
Earnings Call Sentiment|Positive

The call was broadly positive. Stratasys reported revenue growth, strong aerospace and defense momentum, expanding automotive production use cases, growth in Stratasys Direct, improved profitability metrics, positive operating cash flow, and a debt-free balance sheet. The main challenges were the reduced 2026 revenue outlook, longer and more variable sales cycles, flat consumables revenue, continued GAAP losses, the decline in low-end rapid prototyping, and termination of the MarkForged acquisition. Highlights significantly outweighed the lowlights.

Company Guidance

Stratasys updated 2026 revenue guidance to $556 million to $561 million, from the prior range of $565 million to $575 million, implying Q4 revenue of $143 million to $148 million; the company still anticipates that for the full year of 2026, it will have more consumable compared to the full year of 2025, with near-term average-quarter consumables somewhere around the $63 million to $64 million level, and expects 45% to 46% gross margins in the near future. Q4 OpEx is expected to be lower than Q3 and basically from the last 3 quarters, while the company is not providing direction on 2027.

  • Revenue Growth and Manufacturing-Focused TransitionThird-quarter consolidated revenue was $142.6 million, up 4.1% year over year from $137.0 million and up 3.6% sequentially. Management said the results reflected the ongoing shift from rapid prototyping to manufacturing, with manufacturing use-case growth outpacing the decline in rapid prototyping.
  • Strong Aerospace and Defense PerformanceAerospace and defense, the company's largest business, grew over 35% year over year and approximately 25% sequentially. Stratasys highlighted two significant defense orders, strong follow-on activity from existing FDM customers, and demand across drones, space, munitions, EVTOL, advanced air mobility, service bureaus, and contract manufacturers.
  • Growing Qualified Production DemandCustomers continued scaling production programs using Stratasys FDM and SAF technologies, particularly qualified processes for flight-grade applications. Management said once a part is qualified on its platforms, the relationship tends to be long term because requalifying another resource is costly and complex.
  • Automotive Production AdoptionAutomotive grew during the quarter, with General Motors using Stratasys printers to support over 5,000 factory-floor applications this year across more than 20 plants. GM is saving $10 million in annual costs, while tooling response times are roughly 4x faster and worker safety and ergonomics have improved.
  • Expansion of the General Motors PartnershipGM partnered with Stratasys to establish an additive manufacturing center of excellence using a hub-and-spoke model with dozens of industrial 3D printers. The model continued expanding across GM plants in the United States and Mexico.
  • New F870 Platform and Automotive Customer InterestStratasys launched the F870, a large-format FDM platform for factory-floor tooling, fixtures, and end-use parts. Toyota and Rivian were among the first adopters evaluating the system for automotive tooling and manufacturing aids at their North American facilities.
  • FAW Production ExpansionFAW Group continued expanding its use of Stratasys platforms for production. After agreeing to purchase 12 F900 systems, FAW had purchased two in the second quarter and several more in the third quarter, with 17 total F900 systems and eight other Stratasys printers expected by year-end.
  • Stratasys Direct Growth and Record BacklogStratasys Direct's U.S.-based parts manufacturing business grew 9% over the third quarter of last year, supported by robust defense and raw production demand. The backlog for parts production orders was described as higher than ever before across all technologies, with increasing demand for complex, high-requirement contract manufacturing.
  • Improved Stratasys Direct ThroughputThe new F3300 system produced parts at 3x the output of previous systems in one customer case, providing a significant reduction in lead time on an expedited order. Management also cited continued efforts to improve utilization, collect operating data through the manufacturing execution system, and engage AI firms to improve workflow efficiency.
  • Dental Market Approvals and Commercial ProgressStratasys received CDSCO approval in India for its TrueDent material to be used as a medical device. India produces approximately 7 million dentures annually, and management said the technology can introduce dentures at a significantly lower price than current alternatives while addressing wait times that can exceed one year. DDS Lab also launched a direct-to-finish partial denture product line powered by TrueDent and metal 3D printing.
  • Dental Partnerships and Growth OpportunityManagement said the dental business has lined up key partners including Glidewell and Affordable Dentures and believes the business can become a major growth driver once meaningfully commercialized, targeting what it described as a multibillion-dollar opportunity.
  • Improved Gross Margin and Operating ResultsGAAP gross margin was 43.7%, compared with 41.0% in the prior-year quarter, while non-GAAP gross margin was 47.8%, compared with 45.3%. GAAP operating loss improved to $11.0 million from $22.7 million, non-GAAP operating income increased to $2.7 million from essentially breakeven, and adjusted EBITDA rose to $8.0 million from $5.0 million.
  • Lower Net Loss and Positive Operating Cash FlowGAAP net loss was $10.2 million, or $0.12 per diluted share, compared with a $55.6 million, or $0.65 per diluted share, loss in the prior-year quarter. Non-GAAP net income was $3.5 million, or $0.04 per diluted share, compared with $1.5 million, or $0.02 per diluted share. The company generated $3.5 million of positive operating cash flow.
  • Expense Discipline and Continued R&D InvestmentGAAP operating expenses declined to $73.3 million from $78.8 million. Non-GAAP operating expenses were $65.5 million, or 45.9% of revenue, and management said it continues to monitor costs and identify discretionary savings while maintaining its approach to investing in R&D and future technologies. Fourth-quarter operating expenses are expected to be lower than in the third quarter.
  • Debt-Free Balance SheetStratasys ended the quarter with approximately $210.7 million in cash equivalents and short-term deposits and continued to operate debt free. Management said the balance sheet provides financial flexibility to invest in technology and adapt to market developments organically and inorganically.
  • Continued Consumables Growth Expected for 2026Although quarterly consumables revenue was lower than the prior quarter, management continued to expect full-year 2026 consumables revenue to be higher than full-year 2025, with average quarterly levels in the near term expected to be approximately $63 million to $64 million.
  • Strategic Focus on High-Requirement FDM and SAF ApplicationsManagement said Stratasys remains focused on high-requirement, large-format applications and intends for SAF to serve as a backbone for large corporate, aerospace, and defense customers. The company stated that it will not compete with $20,000 or $30,000 SAF machines and said additional platform developments will be introduced.
  • Corporate Social Responsibility ExpansionStratasys expanded its 12-year partnership with Limb-it-less Solution, a university-based nonprofit using its technology to provide hundreds of 3D-printed prosthetic limbs to children across North America and beyond. The expanded program adds a renewed focus on sustainability and education and uses certified pre-owned F-Series printers.

DE:SCY Earnings History

DE:SCY earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 11, 20272026 (Q4)0.05-0.06――
Nov 12, 20262026 (Q3)0.020.040.02100.00% (+0.02)
Aug 13, 20262026 (Q2)0.010.030.030.00% (+0.00)
May 07, 20262026 (Q1)-0.02-0.010.04-125.00% (-0.05)
Mar 05, 20262025 (Q4)0.050.060.11-41.67% (-0.05)
Nov 13, 20252025 (Q3)0.000.020.01100.00% (+0.01)
Aug 13, 20252025 (Q2)0.030.03-0.04175.00% (+0.06)
May 08, 20252025 (Q1)0.010.04-0.02300.00% (+0.05)
Mar 05, 20252024 (Q4)0.100.110.02500.00% (+0.09)
Nov 13, 20242024 (Q3)-0.030.010.04-75.00% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed